Benitec Biopharma Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Benitec Biopharma Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2020 to Q1 2024.
  • Benitec Biopharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $335K, a 43.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $335K -$254K -43.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $400K -$250K -38.5% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $463K -$248K -34.9% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $526K -$245K -31.8% Jun 30, 2023 10-Q 2024-05-13
Q1 2023 $589K -$239K -28.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $650K -$238K -26.8% Dec 31, 2022 10-Q 2023-02-13
Q3 2022 $711K -$236K -24.9% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $771K $0 0% Jun 30, 2022 10-K 2023-09-21
Q1 2022 $828K +$576K +229% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $888K +$588K +196% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $947K +$599K +172% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $771K +$376K +95.2% Jun 30, 2021 10-K 2023-09-21
Q1 2021 $252K Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $300K Dec 31, 2020 10-Q 2021-02-09
Q3 2020 $348K Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $395K Jun 30, 2020 10-K 2021-09-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.